| All (n = 196) | Diarrhoea (n = 29) | No diarrhoea (n = 167) |
---|---|---|---|
Age, mean (SD) | 41 (7) | 41 (7) | 41 (7) |
Male | 93% (183) | 97% (28) | 93% (155) |
Female | 7% (13) | 3% (1) | 7% (12) |
CD4 count, mean (IQR) 1 | 0.17 (0.04-0.29) | 0.11 (0.01-0.20) | 0.18 (0.04-0.29) |
CDC stage 2 | Â | Â | Â |
1 | 22% (43) | 9% (4) | 91% (39) |
2 | 29% (56) | 13% (7) | 88% (49) |
3 | 49% (97) | 19% (18) | 81% (79) |
Risk group | Â | Â | Â |
Homosexual | 85% (166) | 17% (28) | 83% (138) |
Heterosexual | 11% (21) | 5% (1) | 95% (20) |
Haemophiliac | 1% (2) | 0% (0) | 100% (2) |
Intravenous drug use | 4% (7) | 0% (0) | 100% (7) |
Blood transfusion | 1% (1) | 0% (0) | 100% (1) |
HIV-1 SI phenotype | 32% (62) | 21% (13) | 79% (49) |
P24 antigen in serum | 16% (32) | 3% (1) | 97% (31) |
HIV-1 RNA load >4.9 × 10 4 copies/ml | 51% (99) | 19% (19) | 81% (80) |